UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2133-2140

2004

Volltextzugriff (PDF)

Toxicities and Survival of Elderly Patients With Muscle-Invasive Bladder Cancer Treated With Definitive Bladder Preservation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S398-S398

2013

Volltextzugriff (PDF)

Effect of Long-term Hormonal Therapy (vs Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on RTOG 9202

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S26-S26

2013

Volltextzugriff (PDF)

Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S52-S53

2014

Volltextzugriff (PDF)

Radiation Therapy Oncology Group (RTOG) 9413: A Randomized Trial Comparing Whole Pelvic Radiation Therapy (WPRT) to Prostate Only (PORT) and Neoadjuvant Hormonal Therapy (NHT) to Adjuvant Hormonal Therapy (AHT)

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S106-S107

2013

Volltextzugriff (PDF)

Adjuvant Radiation, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of RTOG 0621

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S2-S2

2014

Volltextzugriff (PDF)

RTOG Protocol 05-18: A Phase III Randomized Trial to Evaluate the Efficacy of Zoledronic Acid for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy (RT) and Long-term Luteinizing Hormone-releasing Hormone (LHRH) Agonist for High-grade and/or Locally Advanced Prostate Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S369-S369

2012

Volltextzugriff (PDF)

Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S99-S99

2011

Volltextzugriff (PDF)

A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2009-11, Vol.75 (3), p.S80-S81

2009

Volltextzugriff (PDF)

Developing a National Radiation Oncology Registry (NROR): A Radiation Oncology Institute (ROI) Initiative

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S693-S694, Article S693

2011

Volltextzugriff (PDF)

A Dosimetric Comparison of Conventional Radiotherapy and Helical Tomotherapy (HT) for Total Body Irradiation (TBI)

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S496-S496

2008

Volltextzugriff (PDF)

Long-term Results of an RTOG Phase II Trial (00-19) of External Beam Radiation Therapy Combined with Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S78-S79

2010

Volltextzugriff (PDF)

PTV Margin to Account for Deformation during Prostate IGRT

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S570-S570

2008

Volltextzugriff (PDF)

Determining Margins for Organs at Risk to Account for Anatomic Motion

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S737-S737

2007

Volltextzugriff (PDF)

Long Term Results of a Phase II Trial of Ultrasound-guided Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate (RTOG 98–05)

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S12-S13

2009

Volltextzugriff (PDF)

Independent Interfraction Motion and Deformation of Pelvic Nodes and Prostate in Image Guided Concurrent Irradiation of Prostate and Pelvic Nodes

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S47-S47

2008

Volltextzugriff (PDF)

Variation in the Definition of Clinical Target Volumes for Pelvic Node Conformal Radiation Therapy of Prostate Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S327-S327

2007

Volltextzugriff (PDF)

Prostate Cancer DNA Ploidy and Response to Salvage Hormone Therapy After Radiotherapy With or Without Short-Term Total Androgen Blockade: An Analysis of RTOG 8610

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1238-1248

2003

Volltextzugriff (PDF)

PD-0571 Determining interobserver variability in prostate bed CTV target delineation using MRI

Radiotherapy and oncology, 2022-05, Vol.170, p.S500-S501

2022

Volltextzugriff (PDF)

Clinical course of late-onset bone marrow transplant nephropathy

Nephron (2015), 1993, Vol.64 (4), p.626

1993

Volltextzugriff (PDF)

2215

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S329-S330

2006

Volltextzugriff (PDF)

PD-01.03

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.1-2

2006

Volltextzugriff (PDF)

IMRT simultaneous integrated boost for high-risk prostate cancer

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S632-S633

2004

Volltextzugriff (PDF)

2215: Does Testosterone Influence Radiation-Induced Toxicity In Radiotherapy of the Prostate? A Secondary Analysis of RTOG Protocol 9413

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S329-S330

2006

Volltextzugriff (PDF)

Adjuvant Androgen Deprivation Therapy Offers a “CURE” in Patients with Poor Prognosis Non-Metastatic Prostate Cancer

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S288-S288

2005

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(16)
Radiology
(16)
Science & Technology
(12)
Life Sciences & Biomedicine
(10)
Humans
(9)
Male
(8)
Biological And Medical Sciences
(7)
Adult
(6)
Middle Aged
(6)
Aged
(5)
Female
(5)
Medical Sciences
(5)
Oncology
(5)
Adolescent
(4)
Aged, 80 And Over
(3)
Cells, Cultured
(3)
Child
(3)
Endocrinology & Metabolism
(3)
Prognosis
(3)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02

Toxicities and Survival of Elderly Patients With Muscle-Invasive Bladder Cancer Treated With Definitive Bladder Preservation Therapy

Effect of Long-term Hormonal Therapy (vs Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on RTOG 9202

Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer

Radiation Therapy Oncology Group (RTOG) 9413: A Randomized Trial Comparing Whole Pelvic Radiation Therapy (WPRT) to Prostate Only (PORT) and Neoadjuvant Hormonal Therapy (NHT) to Adjuvant Hormonal Therapy (AHT)

Adjuvant Radiation, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of RTOG 0621

Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

Developing a National Radiation Oncology Registry (NROR): A Radiation Oncology Institute (ROI) Initiative

A Dosimetric Comparison of Conventional Radiotherapy and Helical Tomotherapy (HT) for Total Body Irradiation (TBI)

Long-term Results of an RTOG Phase II Trial (00-19) of External Beam Radiation Therapy Combined with Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate

PTV Margin to Account for Deformation during Prostate IGRT

Determining Margins for Organs at Risk to Account for Anatomic Motion

Long Term Results of a Phase II Trial of Ultrasound-guided Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate (RTOG 98–05)

Independent Interfraction Motion and Deformation of Pelvic Nodes and Prostate in Image Guided Concurrent Irradiation of Prostate and Pelvic Nodes

Variation in the Definition of Clinical Target Volumes for Pelvic Node Conformal Radiation Therapy of Prostate Cancer

Prostate Cancer DNA Ploidy and Response to Salvage Hormone Therapy After Radiotherapy With or Without Short-Term Total Androgen Blockade: An Analysis of RTOG 8610

PD-0571 Determining interobserver variability in prostate bed CTV target delineation using MRI

Clinical course of late-onset bone marrow transplant nephropathy

2215

PD-01.03

IMRT simultaneous integrated boost for high-risk prostate cancer

2215: Does Testosterone Influence Radiation-Induced Toxicity In Radiotherapy of the Prostate? A Secondary Analysis of RTOG Protocol 9413

Adjuvant Androgen Deprivation Therapy Offers a “CURE” in Patients with Poor Prognosis Non-Metastatic Prostate Cancer

Suchergebnisse filtern